<p>Part I: study initiation. intramuscular vaccination: Group A; 1-ml vaccine, Group B; 2 -ml vaccine and Group C; non vaccinated. Part II: 1 month (30 days) post-study initiation (PSI), a second vaccination dose was administered to half of each vaccinated group as follows: A1; 1-ml, B1; 2- ml. Part III: 9 months (267 days) PSI, Group A was injected with 1 ml vaccine, Group B with 2 ml vaccine, Group C was not vaccinated and another group (Group D) was vaccinated with 1- ml. Part IV: 10 months (295 days) PSI, another vaccination dose was administered to half of each vaccinated group as follows: A3; 1- ml, B3; 2- ml, D1; 1- ml.</p
<p>Individuals who receive one dose while above the age of one year are fully protected. Those who r...
<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vacc...
(3A) Frequency of vaccine induced circulating T follicular helper cells in Groups A and B after 2nd ...
<p>All vaccinated groups received a primary vaccination at the start of the experiment. The booster ...
<p>All subjects screened, enrolled and randomized are indicated in the chart. A total of 24 subjects...
Panel A: Cohort 1 received four monthly immunizations (1, 2, 3, 4) and a fifth immunization (5) 33 d...
<p>The study was composed of two phases. In phase 1, one prophylactic and one control group were inv...
<p>Number of subjects assessed for eligibility, enrolled and randomized to study vaccine or placebo....
<p>Five groups of mice (groups of 6) were immunized with different regimens of QH and/or SX H5N1 HA ...
<p>Flow diagram of participation in a longitudinal study, measuring baseline acceptance and subseque...
<p>The CONSORT diagram indicates the number of subjects screened to complete enrollment of 40 subjec...
(A and B) Schematic representing the study design and participant demographics. Participants were ca...
Subjects within each group were randomized 1:1:3 to receive three doses of saline placebo-group 1 or...
Participants were vaccinated three times at 0,1,6 months with Hepatitis B or Na-GST-1 plus Na-APR-1 ...
<p>Flow diagram of the randomized clinical trial of an inactivated subunit influenza A (H7N7) vaccin...
<p>Individuals who receive one dose while above the age of one year are fully protected. Those who r...
<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vacc...
(3A) Frequency of vaccine induced circulating T follicular helper cells in Groups A and B after 2nd ...
<p>All vaccinated groups received a primary vaccination at the start of the experiment. The booster ...
<p>All subjects screened, enrolled and randomized are indicated in the chart. A total of 24 subjects...
Panel A: Cohort 1 received four monthly immunizations (1, 2, 3, 4) and a fifth immunization (5) 33 d...
<p>The study was composed of two phases. In phase 1, one prophylactic and one control group were inv...
<p>Number of subjects assessed for eligibility, enrolled and randomized to study vaccine or placebo....
<p>Five groups of mice (groups of 6) were immunized with different regimens of QH and/or SX H5N1 HA ...
<p>Flow diagram of participation in a longitudinal study, measuring baseline acceptance and subseque...
<p>The CONSORT diagram indicates the number of subjects screened to complete enrollment of 40 subjec...
(A and B) Schematic representing the study design and participant demographics. Participants were ca...
Subjects within each group were randomized 1:1:3 to receive three doses of saline placebo-group 1 or...
Participants were vaccinated three times at 0,1,6 months with Hepatitis B or Na-GST-1 plus Na-APR-1 ...
<p>Flow diagram of the randomized clinical trial of an inactivated subunit influenza A (H7N7) vaccin...
<p>Individuals who receive one dose while above the age of one year are fully protected. Those who r...
<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vacc...
(3A) Frequency of vaccine induced circulating T follicular helper cells in Groups A and B after 2nd ...